Cited by 451

The DOI matches its Crossref record.

Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor

Miles, Lindsey A., Dahlberg, Carol M., Plescia, Janet, Felez, Jordi, Kato, Kanefusa, Plow, Edward F.·1991·Biochemistry

Abstract

Plasminogen binding to cell surfaces results in enhanced plasminogen activation, localization of the proteolytic activity of plasmin on cell surfaces, and protection of plasmin from alpha 2-antiplasmin. We sought to characterize candidate plasminogen binding sites on nucleated cells, using the U937 monocytoid cell as a model, specifically focusing on the role of cell-surface proteins with appropriately placed lysine residues as candidate plasminogen receptors. Lysine derivatives with free alpha-carboxyl groups and peptides with carboxy-terminal lysyl residues were effective inhibitors of plasminogen binding to the cells. One of the peptides, representing the carboxy-terminal 19 amino acids of alpha 2-antiplasmin, was approximately 5-fold more effective than others with carboxy-terminal lysines. Thus, in addition to a carboxy-terminal lysyl residue, other structural features of the cell-surface proteins may influence their affinity for plasminogen. Affinity chromatography has been used to isolate candidate plasminogen receptors from U937 cells. A major protein of Mr 54,000 was recovered and identified as alpha-enolase by immunochemical and functional criteria. alpha-Enolase was present on the cell surface and was capable of binding plasminogen in ligand blotting analyses. Plasminogen binding activity of a molecular weight similar to alpha-enolase also was present in a variety of other cell types. Carboxypeptidase B treatment of alpha-enolase abolished its ability to bind plasm…

Overview

Integrity signals

Registry

Crossref · 10.1021/bi00220a034

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ENO1 is a multifunctional protein that promotes the Warburg effect as a classical glycolytic enzyme and also acts as a plasminogen receptor and DNA-binding protein.

    “ENO1 is a multifunctional protein that not only promotes the Warburg effect as a classical glycolytic enzyme but also acts as a plasminogen receptor and DNA-binding protein (Miles et al., 1991; Ray and Miller, 1991).”

Citations

Cited by

Sorted by citations

Metadata

Authors
Miles, L. A., Dahlberg, C. M., Plescia, J., Felez, J., Kato, K., & Plow, E. F.
Venue
Biochemistry
Published
1991-02
Volume
30
Issue
6
Pages
1682-1691
ISSN
  • 0006-2960
  • 1520-4995
Cited by
451
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review